CRISPR ethical concerns are at the forefront of modern biotechnology debates, particularly as the potential to edit genes opens up possibilities for curing diseases like sickle cell anemia.While the promise of gene editing technology offers hope for many, it simultaneously triggers significant ethical dilemmas regarding medical ethics and health equity.